Cytosorbents (CTSO) Price to Sales (2011 - 2026)

Cytosorbents (CTSO) has reported Price to Sales for 16 consecutive years, with 0.12 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 71.03% year-over-year to 0.12; the trailing twelve-month figure through Jun 2026 stood at 0.03 (down 71.85% YoY), and the FY2025 full-year result was 0.05, down 22.63% from the prior year.
• Price to Sales retreated to 0.12 in Q2 2026 per CTSO's latest filing, from 0.2 in the prior quarter.
• Across five years, Price to Sales topped out at 0.84 in Q2 2023 and bottomed at 0.12 in Q2 2026.
• Historically, Price to Sales has averaged 0.41 across 5 years, with a median of 0.36 in 2022.
• The sharpest annual moves came in 2022 and 2025: Price to Sales plunged 79.77% in 2022, then surged 93.83% in 2025.
• Over 5 years, Price to Sales stood at 0.36 in 2022, then declined by 20.61% to 0.29 in 2023, then slipped by 4.65% to 0.27 in 2024, then retreated by 20.17% to 0.22 in 2025, then slumped by 44.55% to 0.12 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 0.12, 0.2, and 0.22 for Q2 2026, Q1 2026, and Q4 2025 respectively.